Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-18

Clinical Trial Update: IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase [Phase 2]

View source ↗

Summary

Phase 2 trial of IN Insulin for safety in type 1 diabetes with hypoglycemia unawareness; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IN Insulin (IN insulin)

Snippet

Sponsor: HealthPartners Institute | Conditions: Type1diabetes | Phase 2 | Status: TERMINATED | Results posted: 2021-05-18